Trending...
- Spiritually Transformative Events Based on Bhagavad Gita – Path to a Fulfilling Life
- Author Deric Whaley's book 'The Ride' gives unique insider view on prison life
- Enable Accessible Haircare Wins Bronze at 2025 NACD Packaging Awards
BOWIE, Md. - illiNews -- Solomon Eye Physicians and Surgeons is proud to announce the promotion of Dr. Nancy Draskovic to Clinical Director of Ocular Surface Disease, a new leadership role created to advance the organization's commitment to clinical excellence and innovation in patient care.
Dr. Draskovic joined Solomon Eye in 2017 and has consistently demonstrated exceptional expertise in the diagnosis and management of complex ocular conditions. Her collaborative approach, dedication to patient outcomes, and passion for education have made her an invaluable asset to both patients and colleagues alike.
In this new role, Dr. Draskovic will lead the clinical strategy for the Ocular Disease division, supporting best-in-class protocols, mentoring clinical staff, and driving continued advancement in treatment options for conditions such as dry eye, glaucoma, macular degeneration, and diabetic eye disease.
More on illi News
"Dr. Draskovic's promotion reflects both her outstanding clinical leadership and our continued focus on delivering top-tier, patient-centered care," said Dr. Jonathan Solomon, Medical Director at Solomon Eye. "She brings the perfect balance of experience, innovation, and compassion to this role."
Dr. Draskovic holds her Doctor of Optometry from The New England College of Optometry with residency training at the Baltimore VA Medical Center focused on ocular disease. She is an active member of the American Academy of Optometry and frequently lectures on advancements in disease management and interdisciplinary care.
"I'm honored to take on this position and work alongside a team so deeply committed to improving the lives of our patients," said Dr. Draskovic. "Together, we'll continue to raise the standard of care in our community."
For more information about Solomon Eye Physicians and Surgeons and its full range of services, visit www.solomoneye.com.
Dr. Draskovic joined Solomon Eye in 2017 and has consistently demonstrated exceptional expertise in the diagnosis and management of complex ocular conditions. Her collaborative approach, dedication to patient outcomes, and passion for education have made her an invaluable asset to both patients and colleagues alike.
In this new role, Dr. Draskovic will lead the clinical strategy for the Ocular Disease division, supporting best-in-class protocols, mentoring clinical staff, and driving continued advancement in treatment options for conditions such as dry eye, glaucoma, macular degeneration, and diabetic eye disease.
More on illi News
- Tomorrow's World Today Shines Bright with Four Telly Awards at the 46th Annual Telly Awards
- AbbVie Partners with Chicago Cubs on "Striking Out Cancer"
- Chicago: Mayor Brandon Johnson, City Officials, Lamar Johnson Collaborative, and 548 Development Attend Groundbreaking of Mixed-Use West Humboldt Park Development
- ILLINOIS TEAMSTERS DEMAND LAWMAKERS PREVENT CATASTROPHIC CUTS TO PUBLIC TRANSPORTATION
- 6 Love Sports and Eight Sleep Announce Partnership Miami Women's Padel League Rebranded as the Eight Sleep Miami Women's Padel League by 6 Love Sports
"Dr. Draskovic's promotion reflects both her outstanding clinical leadership and our continued focus on delivering top-tier, patient-centered care," said Dr. Jonathan Solomon, Medical Director at Solomon Eye. "She brings the perfect balance of experience, innovation, and compassion to this role."
Dr. Draskovic holds her Doctor of Optometry from The New England College of Optometry with residency training at the Baltimore VA Medical Center focused on ocular disease. She is an active member of the American Academy of Optometry and frequently lectures on advancements in disease management and interdisciplinary care.
"I'm honored to take on this position and work alongside a team so deeply committed to improving the lives of our patients," said Dr. Draskovic. "Together, we'll continue to raise the standard of care in our community."
For more information about Solomon Eye Physicians and Surgeons and its full range of services, visit www.solomoneye.com.
Source: Solomon Eye
0 Comments
Latest on illi News
- Chosen Launches Mobile Family Closet to Serve Foster, Adoptive, and Kinship Families Across Southeastern Wisconsin
- New Release Explores Grit, Wit, and Appalachian Life in We Saved Ourselves, Kinda
- WNC Roofing, LLC Opens Spartanburg, SC Location After a Decade of Serving the Upstate
- June Is Men's Health Month 2025:
- Velocity Performance Alliance Shifts Into High Gear with Luxury Auto Real Estate Platform Ahead of NASCAR Debut
- Floating Water Ramp for Pups is Still Making a Splash
- Intensity Therapeutics, Inc.'s Phase 3 INVINCIBLE-3 Sarcoma Study Selected for Presentation at the American Society of Clinical Oncology (ASCO) 2025 Annual Meeting
- UIFCA Wealth Academy's Revolutionary UIFCA(UFCA) Token Gains Momentum in AI-Powered Investment Market
- Naperville Offering Two New Recycling Programs Starting June 2
- New Website Launch Positions TekTone Builders As Tulsa's Commercial Construction Leader
- Inframark Expands Its Capabilities and Presence in Arizona, Adding Wastewater Experts Mehall Contracting
- FilmHedge Is Letting A.I. Into the Deal Room—And Hollywood Will Never Be the Same
- The Inner Circle acknowledges, Dr. Rashid G. Mosley as a Pinnacle Professional Member
- Naperville: Cook County Convicted Felon Charged with Alleged Illegal Possession of Four Loaded Firearms
- This Artificial Intelligence Platform Could Change How Hollywood Gets Funded Forever
- Chicago: Mayor Johnson Announces $20 Million in Grant Awards for Community Development Projects
- $100 Million Financing Unlocked for Aggressive Acquisition and Growth Strategy Including Plan to Acquire Remote Lottery Platform: Stock Symbol: LTRY
- ARCH Dental + Aesthetics Unveils New Website for Enhanced Patient Experience
- GO2 Partners Named to PPAI 100 List
- Illumina expands clinical oncology portfolio unlocking new standard of care and access to precision therapies